Cargando…
Treating Acute Decompensated Heart Failure in Patients with COVID-19 Using Intravenous Nitroglycerin in 5% Glutathione
The purpose of this current opinion article is to illustrate a novel approach to the treatment of acute decompensated heart failure (ADHF) in coronavirus disease 2019 (COVID-19) patients. The approach described herein relies on a reformulation of intravenous nitroglycerin in 5% glutathione, itself n...
Autores principales: | Kaesemeyer, Wayne, Suvorava, Tatsiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982335/ https://www.ncbi.nlm.nih.gov/pubmed/33748918 http://dx.doi.org/10.1007/s40256-021-00474-w |
Ejemplares similares
-
Ultra‐high dose intravenous nitroglycerin in an ESRD patient with acutely decompensated heart failure
por: Gyory, Michael, et al.
Publicado: (2021) -
Optimizing the Dosing of Intravenous Theophylline in Acute Severe Asthma in Children
por: Saint, Gemma L., et al.
Publicado: (2018) -
Can Pediatric Heart Failure Therapy Be Improved? Yes It Can, But…
por: Schranz, Dietmar
Publicado: (2022) -
Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology
por: Maack, Christoph, et al.
Publicado: (2018) -
Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure
por: Bavendiek, Udo, et al.
Publicado: (2017)